Diagnosis and Treatment Outcomes and Influencing Factors of Multidrug-Resistant Tuberculosis Based on Patient Pathway.
10.3881/j.issn.1000-503X.14972
- Author:
Yan-Li REN
1
;
Bin CHEN
2
;
Jian-Min JIANG
1
Author Information
1. School of Public Health,Hangzhou Normal University,Hangzhou 311121,China.
2. Tuberculosis Prevention and Control Institute,Zhejiang Provincial Center for Disease Control and Prevention,Hangzhou 310021,China.
- Publication Type:Journal Article
- Keywords:
influencing factors;
multidrug-resistant tuberculosis;
patient pathway;
tuberculosis
- MeSH:
Humans;
Antitubercular Agents/therapeutic use*;
Tuberculosis, Multidrug-Resistant/prevention & control*;
Treatment Outcome;
China
- From:
Acta Academiae Medicinae Sinicae
2023;45(2):178-184
- CountryChina
- Language:Chinese
-
Abstract:
Multidrug-resistant tuberculosis (MDR-TB) has become one of the major challenges in the global tuberculosis (TB) control.Despite years of efforts on MDR-TB control,the treatment success rates in China have increased slowly,which indicates possible deficiencies in the management of prevention and control work.Therefore,it is necessary to analyze the current status of MDR-TB prevention and treatment based on the patient pathway.This review summarizes the current drop-out situation of MDR-TB patients in the diagnosis and treatment pathway and the factors affecting patients' outcomes in the whole pathway,so as to provide a scientific reference for the prevention and control of MDR-TB.
